<DOC>
	<DOCNO>NCT01702051</DOCNO>
	<brief_summary>Islet autotransplantation ( IAT ) therapeutic approach use prevent pancreatogenic diabetes reduce severity diabetes major pancreatectomy . Total pancreatectomy IAT use almost exclusively treatment chronic pancreatitis . More recently , indication chronic pancreatitis report include IAT extend pancreatectomy perform resection benign tumor mid-segment pancreas IAT total pancreatectomy severe abdominal trauma In study , study experience IAT treatment broad population patient undergoing pancreatic surgery include subject technically unfeasible high risk pancreatic anastomosis partial pancreatectomy subject undergoing completion pancreatectomy anastomosis leakage pancreatoduodenectomy nonmalignant malignant disease .</brief_summary>
	<brief_title>Extending Indication Islet Autotransplantation Pancreatic Surgery</brief_title>
	<detailed_description />
	<criteria>18 year age ability provide write informed consent fast glycaemia &lt; 126 mg/dl without glucoselowering medication . Any medical condition , opinion investigator , interfere safe completion trial Diagnosis intraductal papillary mucinous cancer , unless absence multifocal lesion demonstrate endoscopic US Presence multifocal residual disease pancreatic margin . If malignat disease reason surgery , 1 cm pancreatic remnant proximity pancreatic margin resect sent immediate pathologic analysis confirm margin negativity rule multifocal tumor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Pancreatogenic diabetes</keyword>
	<keyword>Autologou Islet Transplantation</keyword>
	<keyword>Pancreas</keyword>
	<keyword>Pancreatectomy</keyword>
</DOC>